Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some extracts from the Cohen Report

Re: Blunist, the Cohen report shows over $167 MILLION..../Blunist

posted on Jan 07, 2009 08:45AM

"if you think that we have the potential to get to NASDAQ, then I would say that now is very much "The Ground Floor" (15 cents to $5 is 3,333%).

I believe if the SP can get and hold somwhere around a dollar, I look for RG to do a reverse split to get us to NASDAQ. I don't think we get to $5.00 any other way at least not on the BB and not with 500,000 shares. As the company grows even more and the SP increases they can split the stock to increase shares again later. I think it is advantages at the correct time to get us on the NASDAQ so mutual funds will look at us and we leave the BB. I believe this is RG's plan.

All the best,

Steve

Share
New Message
Please login to post a reply